BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15121238)

  • 1. Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation.
    Freeman W; Morton AJ
    Brain Res Bull; 2004 Mar; 63(1):45-55. PubMed ID: 15121238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.
    Glynn D; Reim K; Brose N; Morton AJ
    Brain Res Bull; 2007 Apr; 72(2-3):108-20. PubMed ID: 17352934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNAP-25 regulation during adrenal gland development: comparison with differentiation markers and other SNAREs.
    Hepp R; Grant NJ; Aunis D; Langley K
    J Comp Neurol; 2000 Jun; 421(4):533-42. PubMed ID: 10842212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential messenger RNA expression of complexins in mouse brain.
    Freeman W; Morton AJ
    Brain Res Bull; 2004 Mar; 63(1):33-44. PubMed ID: 15121237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease.
    Smith R; Klein P; Koc-Schmitz Y; Waldvogel HJ; Faull RL; Brundin P; Plomann M; Li JY
    J Neurochem; 2007 Oct; 103(1):115-23. PubMed ID: 17877635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease.
    Morton AJ; Faull RL; Edwardson JM
    Brain Res Bull; 2001 Sep; 56(2):111-7. PubMed ID: 11704347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
    Smith R; Petersén A; Bates GP; Brundin P; Li JY
    Neurobiol Dis; 2005 Dec; 20(3):673-84. PubMed ID: 15967669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation.
    Zourlidou A; Gidalevitz T; Kristiansen M; Landles C; Woodman B; Wells DJ; Latchman DS; de Belleroche J; Tabrizi SJ; Morimoto RI; Bates GP
    Hum Mol Genet; 2007 May; 16(9):1078-90. PubMed ID: 17360721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synaptic SNARE complex is a parallel four-stranded helical bundle.
    Poirier MA; Xiao W; Macosko JC; Chan C; Shin YK; Bennett MK
    Nat Struct Biol; 1998 Sep; 5(9):765-9. PubMed ID: 9731768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse.
    Gibson HE; Reim K; Brose N; Morton AJ; Jones S
    Eur J Neurosci; 2005 Oct; 22(7):1701-12. PubMed ID: 16197510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
    Wade A; Jacobs P; Morton AJ
    Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of neuronal SNARE assembly by the membrane.
    Kweon DH; Kim CS; Shin YK
    Nat Struct Biol; 2003 Jun; 10(6):440-7. PubMed ID: 12740606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in bax expression and apoptosis are associated in Huntington's disease progression.
    Teles AV; Rosenstock TR; Okuno CS; Lopes GS; Bertoncini CR; Smaili SS
    Neurosci Lett; 2008 Jun; 438(1):59-63. PubMed ID: 18468793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease.
    Jenkins BG; Andreassen OA; Dedeoglu A; Leavitt B; Hayden M; Borchelt D; Ross CA; Ferrante RJ; Beal MF
    J Neurochem; 2005 Oct; 95(2):553-62. PubMed ID: 16135087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose/oxygen deprivation and reperfusion upregulate SNAREs and complexin in organotypic hippocampal slice cultures.
    Park SJ; Jung YJ; Kim YA; Lee-Kang JH; Lee KE
    Neuropathology; 2008 Dec; 28(6):612-20. PubMed ID: 18503508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNAP-29: a general SNARE protein that inhibits SNARE disassembly and is implicated in synaptic transmission.
    Su Q; Mochida S; Tian JH; Mehta R; Sheng ZH
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14038-43. PubMed ID: 11707603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNAREs in native plasma membranes are active and readily form core complexes with endogenous and exogenous SNAREs.
    Lang T; Margittai M; Hölzler H; Jahn R
    J Cell Biol; 2002 Aug; 158(4):751-60. PubMed ID: 12177041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
    Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
    Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease.
    Bisogno T; Martire A; Petrosino S; Popoli P; Di Marzo V
    Neurochem Int; 2008 Jan; 52(1-2):307-13. PubMed ID: 17664017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most peptide-containing sensory neurons lack proteins for exocytotic release and vesicular transport of glutamate.
    Morris JL; König P; Shimizu T; Jobling P; Gibbins IL
    J Comp Neurol; 2005 Feb; 483(1):1-16. PubMed ID: 15672399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.